Corticosteroid Treatment in Critically Ill Patients
- Author:
Sangkil LEE
1
;
Jeong Am RYU
Author Information
- Publication Type:Review
- Keywords: Adrenal insufficiency; Septic shock; Acute respiratory distress syndrome; Intensive care unit
- MeSH: Adrenal Cortex Hormones; Adrenal Insufficiency; Adrenocorticotropic Hormone; Critical Illness; Diagnosis; Edema; Fever; Hemodynamics; Humans; Hydrocortisone; Intensive Care Units; Physiology; Plasma; Respiratory Distress Syndrome, Adult; Sepsis; Shock; Shock, Septic; Steroids; Unconsciousness
- From: Journal of Neurocritical Care 2017;10(2):86-91
- CountryRepublic of Korea
- Language:Korean
- Abstract: Increased levels of tissue corticosteroids are associated with important protective responses of critically ill patients. Critical illness and its treatment interfere with the normal corticosteroid response to illness and induce tissue corticosteroid insufficiency. Therefore, corticosteroid is commonly used in critically ill patients. In intensive care units, the main reasons for using steroids are critical illness-related corticosteroid insufficiency (CIRCI), septic shock, acute respiratory distress syndrome (ARDS), airway edema, etc. CIRCI may be suspected due to symptoms or signs such as unconsciousness, hemodynamic instability, fever, or electrolyte imbalance. An adrenocorticotropic hormone stimulation test or measurement of a random plasma cortisol level is necessary to diagnose CIRCI. Corticosteroid administration can be helpful when CIRCI is confirmed. Similar to CIRCI, corticosteroid can be used in septic shock. However, corticosteroid administration is not recommended for patients with sepsis without shock. The use of corticosteroid in patients with ARDS is still controversial. Although steroids are commonly used for critically ill patients, there are controversies related to the use of steroids in the intensive care unit. In this article, we review the physiology of the corticosteroid response to critical illness and practical issues relating to the diagnosis and treatment of corticosteroid insufficiency in critically ill patients.
